Markets:

Overview

News

Currencies

International

Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

23.24 -0.96 (-3.97%)

Streaming Delayed Price Updated: 12:40 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

ELAN Q2 Deep Dive: Blockbuster Launches and Portfolio Expansion Drive Outperformance

August 06, 2026

Animal health company Elanco (NYSE:ELAN) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.2% year on year to $1.37 bill...

Via StockStory

Elanco Animal Health (NYSE:ELAN) Q2 Earnings Beat, Lifts Full-Year Outlook ↗

August 05, 2026

Via Chartmill

Topics Earnings

Elanco’s (NYSE:ELAN) Q2 CY2026: Strong Sales, Stock Soars

August 05, 2026

Animal health company Elanco (NYSE:ELAN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 10.2% year on year to $1.37 billion...

Via StockStory

Elanco (ELAN) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 03, 2026

Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before market hours. Here’s what you need to know. Elanco beat analysts’ re...

Via StockStory

Elanco Animal Health Inc (NYSE:ELAN) Technical Breakout Setup Scores 10/10 Technical Rating and 9/10 Setup Quality ↗

July 04, 2026

Via Chartmill

Elanco Animal Health (NYSE:ELAN) Soars After Strong Q1 Beat, Raises Full-Year Outlook ↗

May 06, 2026

Via Chartmill

1 Mid-Cap Stock to Own for Decades and 2 We Question

June 24, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

Topics Retirement

1 Profitable Stock to Target This Week and 2 We Avoid

June 16, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

2 Cash-Producing Stocks on Our Buy List and 1 That Underwhelm

June 12, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

3 of Wall Street’s Favorite Stocks We Think Twice About

June 01, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

3 Healthcare Stocks We Keep Off Our Radar

May 28, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...

Via StockStory

What This Fund's $20 Million Sale Says About a Packaging Giant Facing a Turnaround Test ↗

May 23, 2026

Graphic Packaging supplies fiber-based packaging for global consumer and foodservice brands, with a focus on sustainability and scale.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About This Fund's $85 Million Lionsgate Buy During a Breakout Quarter ↗

May 23, 2026

Lionsgate Studios leverages a vast film and TV library to serve global broadcasters, streamers, and distributors with premium content.

Via The Motley Fool

Topics Intellectual Property

Q1 Rundown: Elanco (NYSE:ELAN) Vs Other Pharmaceuticals Stocks

May 20, 2026

Looking back on pharmaceuticals stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Elanco (NYSE:ELAN) and its peers. The pha...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Black Creek trims PriceSmart after a strong run — conviction intactBlack Creek trims PriceSmart after a strong run — conviction intact ↗

May 19, 2026

PriceSmart runs membership warehouse clubs across the Americas, providing essential goods and services to value-driven customers.

Via The Motley Fool

Topics Regulatory Compliance

3 Reasons to Sell ELAN and 1 Stock to Buy Instead

May 15, 2026

Since November 2025, Elanco has been in a holding pattern, floating around $21.39. The stock also fell short of the S&P 500’s 11.5% gain during that period. ...

Via StockStory

Topics Stocks

5 Insightful Analyst Questions From Elanco’s Q1 Earnings Call

May 13, 2026

Elanco’s first quarter results were met with a positive market reaction, as management pointed to broad-based revenue growth across its pet health and farm a...

Via StockStory

Topics Earnings

Elanco Animal Health Q1 Earnings Call Highlights ↗

May 10, 2026

Elanco Animal Health (NYSE:ELAN) raised its 2026 outlook after reporting stronger-than-expected first-quarter results, citing broad-based growth across pet health and farm animal businesses,...

Via MarketBeat

Topics Earnings

ELAN Q1 Deep Dive: Innovation Products and Margin Expansion Steer Strong Start

May 07, 2026

Animal health company Elanco (NYSE:ELAN) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 14.9% year on year to $1.37 bill...

Via StockStory

Elanco (ELAN) Q1 2026 Earnings Transcript ↗

May 06, 2026

Elanco (ELAN) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Economy

Elanco’s (NYSE:ELAN) Q1 CY2026 Sales Beat Estimates

May 06, 2026

Animal health company Elanco (NYSE:ELAN) announced better-than-expected revenue in Q1 CY2026, with sales up 14.9% year on year to $1.37 billion. The company ...

Via StockStory

Topics Earnings

Elanco (ELAN) Q1 Earnings: What To Expect

May 04, 2026

Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before the bell. Here’s what investors should know. Elanco beat analysts’ r...

Via StockStory

Topics Artificial Intelligence

Winners And Losers Of Q4: Elanco (NYSE:ELAN) Vs The Rest Of The Pharmaceuticals Stocks

April 22, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the pharmaceuticals stocks, including Elanco (NYSE:ELAN) and its peers. The pharmaceuti...

Via StockStory

Topics Artificial Intelligence Intellectual Property

3 Mid-Cap Stocks Walking a Fine Line

April 13, 2026

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

April 06, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

Topics Artificial Intelligence

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Government Stocks

1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds

March 23, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...

Via StockStory

Topics Artificial Intelligence

Elanco (ELAN): Buy, Sell, or Hold Post Q4 Earnings?

March 12, 2026

Elanco’s 26.6% return over the past six months has outpaced the S&P 500 by 23.6%, and its stock price has climbed to $23.47 per share. This was partly thanks...

Via StockStory

Topics Stocks

Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy Government World Trade

USDA Deploys $100 Million 'Screwworm Challenge' to Safeguard U.S. Livestock and Dairy Frontier

March 02, 2026

The United States Department of Agriculture (USDA) has officially greenlit a massive $100 million initiative dubbed the "Screwworm Challenge," aimed at neutralizing a resurgent biological threat that...

Via MarketMinute

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.